Skip to main
HQY

HealthEquity (HQY) Stock Forecast & Price Target

HealthEquity (HQY) Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 20%
Buy 70%
Hold 0%
Sell 0%
Strong Sell 10%

Bulls say

HealthEquity is well positioned to benefit from sustained share gains, with total HSA members up 8% year over year, custodial assets up 14%, and renewals tracking well above 90%, while rising deductibles and broader HSA eligibility continue to expand its addressable market. Its digital platform strengthens the moat: the app surpassed 1.4 million monthly active users in July, marketplace traffic hit a record 500,000 unique visitors in a week, and only about 9% of HSA members invest today, leaving meaningful monetization upside through products like SimplyInvest and Enhanced Rates. Management’s emphasis on AI, automation, and a larger enterprise pipeline supports margin expansion and lower servicing costs, reinforcing the view that HealthEquity can outgrow the market while improving profitability.

Bears say

HealthEquity is vulnerable to a softer labor market, because lower employment and weaker high-income job growth can slow HSA contributions, new account growth, and average balance expansion, pressuring a business that depends on consumer savings accumulation. Its earnings mix is also sensitive to falling interest rates and investment returns, and the cited downside case assumes a recession-like environment with only 5% topline growth and 200 bps of margin contraction in 2027. In addition, competition, regulatory risk around tax-advantaged benefits, cybersecurity threats, and possible shifts toward alternative payment methods could all limit valuation support despite solid operational execution.

HealthEquity (HQY) has been analyzed by 10 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 70% recommend Buy, 0% suggest Holding, 0% advise Selling, and 10% predict a Strong Sell.

This aggregate rating is based on analysts' research of HealthEquity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HealthEquity (HQY) Forecast

Analysts have given HealthEquity (HQY) a Buy based on their latest research and market trends.

According to 10 analysts, HealthEquity (HQY) has a Buy consensus rating as of Oct 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $114.30, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $114.30, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HealthEquity (HQY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.